Slide 1: Q4 and Full Year 2022 Results
Q4 and Full Year 2022 Results Nasdaq Global Market: CCLD, CCLDP, CCLDO A leading healthcare technology company with a complete suite of proprietary, cloud-based solutions for healthcare providers © CareCloud, Inc. 2023
Slide 2: Safe Harbor Statements
Safe Harbor Statements This presentation contains forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statemen
Slide 3: Hosts for Fourth Quarter Earnings Call
Hosts for Fourth Quarter Earnings Call Mahmud Haq Executive Chairman A. Hadi Chaudhry CEO and President Bill Korn Chief Financial Officer Kimberly Blanche General Counsel © CareCloud, Inc. 2023 2
Slide 4: Hadi Chaudhry
Hadi Chaudhry CEO and President © CareCloud, Inc. 2023 3
Slide 5: CareCloud Wellness
CareCloud Wellness © CareCloud, Inc. 2023 4
Slide 6: medSR Update
medSR Update © CareCloud, Inc. 2023 5
Slide 7: Our Tech-Enabled Revenue Cycle Solution
Our Tech-Enabled Revenue Cycle Solution © CareCloud, Inc. 2023 6
Slide 8: Organic Growth
Organic Growth © CareCloud, Inc. 2023 7
Slide 9: Physical Therapy EHR
Physical Therapy EHR © CareCloud, Inc. 2023 8
Slide 10: Emerging Opportunities
Emerging Opportunities Map from Gulf Cooperation Council - Gulf Cooperation Council - Wikipedia © CareCloud, Inc. 2023 9
Slide 11: Bill Korn
Bill Korn Chief Financial Officer © CareCloud, Inc. 2023 10
Slide 12: Q4 2022 and FY 2022 Highlights
Q4 2022 and FY 2022 Highlights 25.00 25.00 14% 145.00 6. 0 0% - 10% 125.00 5. 0 20.00 20.00 13% - 20% 105.00 - 30% 4. 0 15.00 15.00 13% - 40% 85.00 3. 0 - 50% 65.00 10.00 10.00 12% - 60% 2. 0 - 70% 45.00 5. 0 5. 0 12% - 80% 1. 0 25.00 - 90% - - 100% - - 11% 5. 0 $ in millions. Percent change reflect
Slide 13: FY 2022 Revenues
FY 2022 Revenues 1 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0 Most customers who utilize technology-enabled revenue cycle management use one or more elements of CareCloud’s core technology (EHR or PM) © CareCloud, Inc. 2023 12
Slide 14: Revenue 2021 – 2022 plus 2023 Guidance: 12% Net Organic Growth
Revenue 2021 – 2022 plus 2023 Guidance: 12% Net Organic Growth ($ in millions) 160 .0 Total Revenue 140 .0 120 .0 Excluding 2 large 100 .0 customers each acquired prior to our taking over 80.00 their contracts via one of our 2020 acquisitions60.00 40.00 20.00 - Percentages represent year-over-year g
Slide 15: Adjusted EBITDA 2021 – 2022 plus 2023 Guidance: 15% Growth
Adjusted EBTIDA 2021 – 2022 plus 2023 Guidance: 15% Growth 29.00 ($ in millions) 24.00 19.00 14.00 9. 0 4. 0 ( 1.00) Investors are cautioned that such statements involve risks and uncertainties that could cause actual results to differ materially from anticipated results See reconciliations of non-G
Slide 16: Capitalization as of February 17, 2023
Capitalization as of February 17, 2023 Series A Series B Common Stock Preferred Stock Preferred Stock Stock Symbol Nasdaq: CCLD Nasdaq: CCLDP Nasdaq: CCLDO Stock Price1 $4.11 $27.59 $25.05 Outstanding 15.4 million 4.5 million 1.4 million Shares1 Equity Value $63 million $125 million $35 million Shar
Slide 17: Thank You
Thank You © CareCloud, Inc. 2023 16
Slide 18: Appendix
Appendix © CareCloud, Inc. 2023 17
Slide 19: Non-GAAP Financial Measures Reconciliation
Non-GAAP Financial Measures Reconciliation © CareCloud, Inc. 2023 18